The pre-filled syringe formulation of Eylea can now be prescribed at general hospitals in Korea.

According to industry sources, Bayer Korea's Wet Age-Related Macular Degeneration (wAMD) treatment 'Eylea Pre-filled Syringe,’ which was released with insurance reimbursement in October last year, has passed the drug committee reviews of tertiary hospitals in Korea, including the Seoul National University Hospital and Asan Medical Center.

As a prefilled injection formulation, Eylea Pre-filled Syringes reduce preparation time for drug administration by allowing injection of a more accurate single dose than the existing Eylea vial formulations. The formulation offers easier administration with